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Background: Low serum magnesium levels have been associated with multiple chronic diseases. The regulation
of serum magnesium homeostasis is not well understood. A previous genome-wide association study (GWAS) of
European ancestry (EA) populations identified nine loci for serum magnesium. No such study has been conducted in
African-Americans, nor has there been an evaluation of the interaction of magnesium-associated SNPs with
environmental factors. The goals of this study were to identify genetic loci associated with serum magnesium in
an African-American (AA) population using both genome-wide and candidate region interrogation approaches
and to evaluate gene-environment interaction for the magnesium-associated variants in both EA and AA populations.
We conducted a GWAS of serum magnesium in 2737 AA participants of the Atherosclerosis Risk in Communities (ARIC)
Study and interrogated the regions of the nine published candidate loci in these results. Literature search identified the
influence of progesterone on MUC1 expression and insulin on TRPM6 expression.
Results: The GWAS approach in African-American participants identified a locus near MUC1 as genome-wide significant
(rs2974937, beta = −0.013, p = 6.1x10−9). The candidate region interrogation approach identified two of the nine
loci previously discovered in EA populations as containing SNPs that were significantly associated in African-American
participants (SHROOM3 and TRPM6). The index variants at these three loci together explained 2.8 % of the variance in
serum magnesium concentration in ARIC African-American participants. On the test of gene-environment interaction in
ARIC EA participants, the index variant at MUC1 had 2.5 times stronger association in postmenopausal women
with progestin use (beta = −0.028, p = 7.3x10−5) than in those without any hormone use (beta = −0.011, p = 7.0x10−8,
p for interaction 0.03). At TRPM6, the index variant had 1.6 times stronger association in those with lower fasting insulin
levels (<80pmol/L: beta = −0.013, p = 1.6x10−7; ≥80pmol/L: beta = −0.008, p = 1.8x10−2, p for interaction 0.03).
Conclusions: We identified three loci that explained 2.8 % of the variance in serum magnesium concentration in
ARIC African-American participants. Following-up on functional studies of gene expression identified gene-environment
interactions between progestin use and MUC1 and between insulin and TRPM6 on serum magnesium concentration in
ARIC European-American participants. These results extend our understanding of the metabolism of serum magnesium.
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Low serum magnesium levels have been associated with
multiple common chronic diseases, including cardio-
vascular diseases [1], hypertension [2], diabetes [3], and
chronic kidney disease [4]. The regulation of serum
magnesium hemostasis is not well understood. The
heritability of serum magnesium is estimated to be
27 % [5], suggesting genetic association studies of
serum magnesium can improve our understanding of
serum magnesium metabolism. A genome-wide associ-
ation study (GWAS) in populations of European ances-
try (EA) previously identified nine loci associated with
serum magnesium levels [6], and these loci explained
<2 % of serum magnesium inter-individual variation
[6]. African-Americans (AA) are known to have lower
serum magnesium levels [7], and no results from
GWAS in AA populations have been reported. It is
known that associated variants may be ancestry-specific
[8]. Gene-environment interactions can also modify
genetic effects. The investigation of genetic associations
across ethnic groups and the identification of gene-
environment interactions have the potential to increase
our understanding of the regulation of serum magne-
sium levels. The goals of the present study were to 1)
identify genomic loci associated with serum magnesium
in AA individuals using both genome-wide and candidate
region interrogation approaches and 2) follow up on
the GWAS findings from EA populations, to identify
environmental factors that may modify the association
between genetic loci and serum magnesium in both EA
and AA populations.
We conducted a GWAS of serum magnesium in
2737 AA participants of the Atherosclerosis Risk in
Communities (ARIC) Study and interrogated the re-
gions of the nine published candidate loci from EA
populations in the AA GWAS results. Index variants
at loci that reached suggestive significance in AA par-
ticipants of the ARIC study were put forward for repli-
cation in the Healthy Aging in Neighborhoods of
Diversity across the Life Span (HANDLS) study. Gene-
environment interaction analyses were conducted in the
ARIC study for MUC1 and TRPM6 based on the results
of literature search, which identified the influence of pro-




In the ARIC study, the sample sizes were 2,737 for AA par-
ticipants and 8,926 for EA participants with mean serum
magnesium levels of 0.79 mmol/L and 0.83 mmol/L
respectively (Table 1). The HANDLS study included
942 AA participants with mean serum magnesium
levels of 0.77 mmol/L.Serum magnesium loci in ARIC African-American
participants
The GWAS in AA participants identified 17 SNPs near or
at MUC1 as genome-wide significant. The index SNP in
ARIC AA participants was rs2974937 at THBS3, 2.7 kb
upstream of MUC1, (beta = −0.013, frequency = 0.32,
p = 6.1x10−9, Table 2). The index SNP previously iden-
tified in EA populations, rs4072037, was also genome-
wide significant (beta = −0.014 mmol/L, frequency =
0.32, p = 2.2x10−8, Additional file 1: Table S1). The
two index SNPs, rs4072037 and rs2974937, were in
high linkage disequilibrium (r2 > 0.7 and D’ > 0.9 in
ARIC EA and AA participants and the 1000 Genomes
Phase 1 data, Additional file 1: Table S2). Fig. 1 presents
the plot of –log10(P-values) by genomic position of the
GWAS of serum magnesium in ARIC AA participants,
and Additional file 1: Figure S1 and S2 present the
quantile-quantile plot of the GWAS results and regional
association plots of theMUC1 locus, respectively.
The index SNPs at eight other loci identified in EA pop-
ulations did not have significant association (meta-analysis
p > 0.01) with serum magnesium in AA participants of the
ARIC and HANDLS studies (Additional file 1: Table S1).
In the GWAS of ARIC AA participants, SNPs at five other
loci showed suggestive significance (MAF ≥5 % and p-
value <10−6, Additional file 1: Table S3). The index
SNPs at these loci were not significantly associated with
serum magnesium in the HANDLS study. The imput-
ation quality of these index SNPs ranged from 0.58 to
0.97 in AA participants of the ARIC and HANDLS
studies.
On the candidate region interrogation, the AA-specific
index SNPs at five loci previously identified in EA popula-
tions (MUC1, MDS1, SHROOM3, TRPM6, and PRMT7)
met the region-specific significant threshold (Table 2). The
index SNPs at three of these five loci were replicated in
the HANDLS study (MUC1, SHROOM3, and TRPM6).
The AA-specific index SNPs at these three loci had imput-
ation quality ≥ 0.87 in the AA participants of the ARIC
and HANDLS studies. In addition, at MUC1 and TRPM6,
at least one genotyped SNP in ARIC AA participants was
associated with serum magnesium below the region-
specific threshold (Additional file 1: Table S4). Additional
file 1: Figs. S2, S3, S4 present the regional association plots
from ARIC AA participants for these three loci. Enhance-
ment enrichment tests using HaploReg showed all three
loci were enriched for enhancers in one or more cell lines
(Additional file 1: Table S5).
Effect modification between the index SNP at MUC1 and
progestin use
The analysis for effect modification between MUC1 and
progestin use was conducted in EA participants only, be-
cause in the ARIC AA participants only 24 postmenopausal
Table 1 Study Participant Characteristics in the ARIC and HANDLS Studies
ARIC study HANDLS study
European-Americans African-Americans African-Americans
N 8926 2737 942
Age, mean (SD) 54.3 (5.7) 53.4 (5.8) 48.3 (9.0)
Female, % (n) 53.0 (4728) 62.6 (1714) 55.9 (527)
Prevalent diabetes, % (n) 8.4 (749) 18.7 (513) 32.2 (303)
Diuretic use, % (n) 14.5 (1297) 28.8 (788) 13.6 (128)
Estimated glomerula filtration rate (mL/min/1.73 m2), mean (SD) 93.3 (12.7) 103.8 (18.0) 96.3 (24.1)
Serum Mg (mmol/L), mean (SD) 0.83 (0.07) 0.79 (0.08) 0.77 (0.08)
Abbreviation: SD, standard deviation
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genotype of the index SNP at MUC1 in EA populations,
rs4072037, was independent of progestin use (Chi-square
p = 0.21). In women with progestin use, the effect size
of rs4072037 was more than two-fold larger (beta =
−0.028 mmol/L, p = 7.3x10−5) than in other groups with-
out progestin use (p for interaction = 0.01 to 0.05, Table 3).
The phenotypic variance explained by rs4072037 in
women with progestin use was 6.5 % versus ≤1.2 % for all
other groups.
Effect modification between the index SNPs at TRPM6
and fasting insulin
At TRPM6, the index SNP identified in EA populations
[6], rs11144134, had very low frequency in ARIC AA
participants (MAF = 2 %), and the index SNP in AA par-
ticipants, rs113607577 (Table 2), was monomorphic in
ARIC EA participants. Thus, the analysis for the effect
modification between TRPM6 and fasting insulin levels
was conducted in EA and AA participants using the
index SNP within the respective populations. The most
likely genotype of the index SNPs in both cohorts was
independent of insulin levels (Chi-square p = 0.77 in EA
participants and 0.49 in AA participants).
In ARIC EA participants, the association between
rs11144134 and serum magnesium levels was stronger in
individuals with lower fasting insulin levels (<80 mmol/L,
beta = −0.013, p = 1.6x10−7) than in those with higher
fasting insulin levels (≥80 mmol/L, beta = −0.008, p = 0.02,
p for interaction = 0.03, Table 4). Similarly, in ARIC AA
participants, the association between rs113607577 and
serum magnesium levels was also stronger in individuals
with lower fasting insulin levels (<80 mmol/L, beta =
−0.026, p = 3.5x10−6) than in those with higher fasting in-
sulin levels (≥80 mmol/L, beta = −0.014, p = 9.0x10−3, p for
interaction = 0.24).
Two nonsynonymous SNPs at TRPM6 were reported
to impair the response of TRPM6 to higher insulin levels
(rs2274924 [K1584E] and rs3750425 [V1393I]) [9]. These
two SNPs were in moderate linkage disequilibrium with
the GWAS index SNPs at this locus (D’ between 0.44 to0.74 in ARIC EA and AA participants, Additional file 1:
Table S6). In ARIC EA participants, the association be-
tween these two nonsynonymous SNP with serum mag-
nesium appeared to be independent of rs11144134, the
GWAS index SNP in EA populations. In ARIC AA par-
ticipants, these two nonsynonymous SNPs were not as-




Three of nine loci associated with serum magnesium
previously discovered in EA populations were found to
be associated in AA populations (MUC1, TRPM6, and
SHROOM3). MUC1 was genome-wide significant in
ARIC AA participants. Together the index SNPs at these
three loci explained 2.8 % of serum magnesium variation
in ARIC AA participants. In addition, we showed that in
ARIC EA participants, the associations of serum magne-
sium with MUC1 and TRPM6 were modified by proges-
tin use and insulin levels respectively, extending the
findings of functional experiments on gene expression to
genetic association studies at the population level.
In the context of the literature
The effect modification between the index SNP at
MUC1 and progestin use on serum magnesium levels is
consistent with the known gene function of MUC1 and
supports MUC1 as the causal gene at this locus. MUC1
encodes a transmembrane mucin that forms part of the
mucosal barrier in the intestine [10] and is also
expressed in the kidney [11]. Higher progesterone levels
increase the expression of MUC1 in endometrial cells
through increased promoter activity [12, 13]. The index
SNPs in ARIC EA and AA participants were 6.7 kb apart
and in high linkage disequilibrium, suggesting the two
populations may share the same causal variant(s). The
index SNP reported in EA populations (rs4072037), at
<1 kb upstream of the transcription start site, is in a
regulatory region [14] and in moderate linkage disequi-
librium with an expression tag SNP (rs4971093) of
Table 2 Association between Loci Identified in Populations of European Ancestry and Serum Magnesium in African-American Populations
ARIC study African-American HANDLS study African-American Meta-analysis












Beta P-Value P-Value threshold
in region
MUC1 rs2974937 1 155168849 C/T 0.32 −0.013 0.002 6.1E-09 0.95 0.35 −0.007 3.5E-02 0.99 −0.012 2.1E-11 8.9E-04
MDS1 rs74516251 3 168830777 A/G 0.11 −0.013 0.003 1.6E-04 0.99 0.11 −0.005 3.3E-01 0.97 −0.011 2.0E-05 4.9E-04
SHROOM3 rs9993810 4 77614640 A/G 0.47 −0.008 0.002 1.8E-04 0.92 0.48 −0.008 3.5E-02 0.93 −0.008 6.1E-06 7.4E-04
TRPM6 rs113607577 9 77455459 G/C 0.90 −0.019 0.004 1.1E-07 0.90 0.89 −0.012 4.7E-02 0.87 −0.017 4.6E-07 1.5E-03
DCDC51 rs7947033 11 30795987 C/T 0.10 −0.011 0.004 5.4E-03 0.74 0.08 −0.001 8.3E-01 0.91 −0.008 1.4E-02 1.0E-03
ATP2B11 rs36089488 12 90118300 T/C 0.95 −0.015 0.005 5.0E-03 0.78 0.94 −0.013 1.0E-01 0.85 −0.015 6.5E-04 9.8E-04
HOXD91 rs6745764 2 176974122 G/A 0.67 −0.008 0.002 9.5E-04 0.82 0.69 −0.005 1.9E-01 0.90 −0.007 3.1E-05 8.5E-04
LUZP2 rs11027876 11 24412973 G/C 0.18 −0.009 0.003 1.3E-03 0.86 0.18 −0.001 8.3E-01 0.89 −0.007 8.1E-03 6.4E-04
PRMT7 rs55857142 16 68236741 T/A 0.07 −0.018 0.004 2.7E-05 0.95 0.07 0.006 3.5E-01 0.97 −0.012 7.1E-04 9.4E-04
Betas are in mmol/L
Abbreviation: freq., frequency; Chr, chromosome; SNP, single nucleotide polymorphism; SE, standard error; imput. qual., imputation quality
Bold indicates significant association in African-American populations based on genome-wide or region-specific p-value threshold and replication in the HANDLS study. The I2, an indicator for heterogeneity between













Fig. 1 A plot of –log10(P-values) by genomic position of the GWAS results of serum magnesium in ARIC African-American participants
Tin et al. BMC Genetics  (2015) 16:56 Page 5 of 9MUC1 [15]. The minor allele of the index SNP was asso-
ciated with decreased serum magnesium levels with sig-
nificantly stronger association in women with progestin
use. A potential explanation could be that the role of
MUC1 as part of the intestinal mucosal barrier affects
the paracellular absorption of magnesium, and that gen-
etic effects on MUC1 become more apparent when there
is increased MUC1 expression.
In contrast, TRPM6 is a magnesium transporter in-
volved in active magnesium absorption in the intestine
and reabsorption in the distal convoluted tubule of the
kidney [16, 17]. Higher insulin levels increase the ex-
pression of TRPM6 mediated by insulin receptors [9].
Although the index SNPs at this locus in EA and AA
participants were not in high linkage disequilibrium and
more than 25 kb apart, the major alleles of both index
SNPs were associated with lower serum magnesium
levels. This association was attenuated in individuals
with higher insulin levels. If higher insulin increases the
transcription of TRPM6 and leads to increase magne-
sium absorption, a potential explanation could be that
the effect of the causal variant(s) at TRPM6 is less appar-
ent when there are more TRPM6 receptors to transport
magnesium. Since magnesium transport in kidney and
intestine also occurs through additional routes and there
are multiple ways by which higher insulin could influence




Female, premenopausal 1428 −0.012
Female, postmenopausal with no hormone use 2495 −0.011
Female, postmenopausal with non-progestin hormone use 574 −0.005
Female, postmenopausal with progestin use 231 −0.028also conceivable. The GWAS index SNPs in ARIC EA and
AA participants were largely independent of the two non-
synonymous SNP found to influence TRPM6 transcription
levels [9]. This suggests that multiple functional variants
associated with serum magnesium exist at TRPM6.
Strengths and limitations
The strengths of this study include sufficient sample size
for identifying the associations of serum magnesium loci
previously discovered in EA populations in ARIC AA
participants using a candidate region interrogation ap-
proach. We also have adequate sample size to assess
gene-environment interaction in ARIC EA participants.
Some limitations warrant mentioned. The suggestive sig-
nificant serum magnesium loci identified in ARIC AA
participants did not replicate in the HANDLS study,
which could be due to a number of reasons, including
limited power, moderate imputation quality, or type I
error in the discovery sample. The association of the
AA-specific index SNP at SHROOM3 with serum magne-
sium has not been verified by genotyped SNPs, although
the association was replicated in the HANDLS study. The
interaction between MUC1 and progestin use in ARIC EA
participants was not assessed in another study. The inter-
action between TRPM6 and insulin levels was significant
in ARIC EA participants but not in ARIC AA participants.
However, the direction of association was consistentMagnesium by Gender and Progestin Use Status in ARIC
mol/L) SE P-Value Variance explained P-Value for interaction
0.002 7.5E-09 0.8 % 0.02
0.003 2.8E-05 1.2 % 0.05
0.002 7.0E-08 1.1 % 0.03
0.004 2.4E-01 0.2 % 0.01
0.007 7.3E-05 6.5 % Reference
Table 4 Association between Index SNPs at TRPM6 and Serum Magnesium by Fasting Insulin Levels in ARIC European and African
Americans
N Beta (mmol/L) SE P-Value Variance explained P for interaction
European-Americans (rs11144134 T allele, frequency 0.92)
Fasting insulin < 80pmol/L 5937 −0.013 0.002 1.6E-07 0.44 % 0.03
Fasting insulin≥ 80pmol/L 2752 −0.008 0.003 1.8E-02 0.19 %
African-Americans (rs113607577 G allele, frequency 0.90)
Fasting insulin < 80pmol/L 1186 −0.026 0.006 3.5E-06 1.55 % 0.24
Fasting insulin≥ 80pmol/L 1302 −0.014 0.005 9.0E-03 0.58 %
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analysis suggests the lack of significant association on the
interaction between TRPM6 and insulin levels in ARIC
AA participants is likely due to low power.
Conclusion
In summary, we identified three loci (MUC1, SHROOM3,
and TRPM6) as associated with serum magnesium in
African-Americans. In addition, we showed that two
serum magnesium associated loci, MUC1 and TRPM6,
had significant effect modification with progestin use and
insulin levels, respectively, in European Americans. These
findings extend previous research on magnesium metabol-
ism and demonstrate gene-environment interaction can
be identified systematically by following up on findings
from gene expression functional experiments.
Methods
Study population
The ARIC Study is a community-based prospective obser-
vational study of individuals between the ages of 45 and
64 years. Participants were drawn from a probability-based
sample from 4 US communities (Forsyth County, NC;
Jackson, MS; suburban Minneapolis, MN; and Washington
County, MD). The baseline visit occurred between 1987
and 1989. Details of the ARIC cohort have been published
elsewhere [18].
Of the total 15,792 participants in the ARIC study,
9,044 EA and 2,874 AA participants had genotypes that
met quality control criteria for GWAS (Additional file 1:
Supplementary Methods section). Participants with esti-
mated glomerular filtration rate (eGFR) <30 mL/min/
1.73 m2 (7 in EA, 97 in AA), missing diabetes status (12
in EA, 10 in AA), missing serum magnesium or having
serum magnesium outside of 3 standard deviations
within the specific population (99 in EA, 30 in AA) were
not included in the analysis. As a result, the analyzed
sample in the ARIC study included 8,926 EA partici-
pants and 2,737 AA participants. The threshold of
30 mL/min/1.73 m2 for eGFR was applied because the
kidney’s ability to maintain serum magnesium levels
within normal range deteriorates substantially wheneGFR falls below this level [19]. Among EA participants,
mean serum magnesium levels were slightly higher in
those included in the analysis (0.83 mmol/L) than in
those excluded (0.82 mmol/L, p = 0.003). Among AA
participants, mean serum magnesium levels were similar
between those included and excluded in the analysis
(0.79 mmol/L in both).
The HANDLS study, the replication cohort for serum
magnesium association in African-Americans, is a
community-based, longitudinal study of socioeconomi-
cally diverse AA and EA individuals in Baltimore [20]. A
total of 942 AA participants with imputed genotype and
data in serum magnesium and covariates were included
in the replication analysis.Serum magnesium and other measures
In the ARIC study, serum magnesium was measured using
the metallochromic dye, Calmagite, based on the proced-
ure of Gindler and Heth [21]. Prevalent diabetes mellitus
was defined as a having a fasting glucose level at least
126 mg/dL, nonfasting glucose level at least 200 mg/dL,
self-reported use of diabetes medication or self-reported
physician diagnosis of diabetes. eGFR was calculated from
standardized serum creatinine using the equation devel-
oped by the Chronic Kidney Disease Epidemiology Collab-
oration (CKD-EPI) [22]. Postmenopausal hormone use
was determined based on inspection of medication bottles.
Menopausal status was based on self-reported. Fasting
serum insulin was measured using a radioimmunoassay
(125Insulin Kit, Cambridge Medical Diagnostics, Billerica,
Massachusetts) which was not specific for insulin and
contained some cross-reactivity with pro-insulin. The de-
tails of the validity and reproducibility of this assay have
been previously published [23].
In the HANDLS study, serum magnesium was mea-
sured using a spectrophotometry assay by Quest Diag-
nostics Nichols institute (Chantilly Virginia). Prevalent
diabetes mellitus was defined as a having a fasting glu-
cose level at least 126 mg/dL or self-reported of diabetes.
eGFR was calculated from standardized serum creatinine
using the CKD-EPI equation [22].
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Details of genotyping, quality control, and imputation
are reported in the Additional file 1: Supplementary
Methods section. Briefly, genotyping was performed
using the Affymetrix Genome-wide Human SNP Array
6.0 in the ARIC study and the Illumina 1 M array in the
HANDLS study. In both studies, individuals who were an-
cestry outlier or had cryptic relatedness were excluded.
Imputation in AA participants in both studies was con-
ducted using genotyped SNPs with MAF > 0.01, call rate >
0.95, and Hardy-Weinberg equilibrium p-value > 0.00001
and the 1000 Genomes March 2012 reference panels. The
imputed genotype dosages were further filtered by MAF <
0.01 and imputation quality <0.3.
Statistical methods for genome-wide association study
and candidate Region interrogation
We conducted a GWAS in the ARIC AA participants
using linear regression with serum magnesium as the out-
come controlling for age, center, gender, prevalent diabetes
status, eGFR and its squared term, diuretic use, and
genotype-based principal components with significant as-
sociation (p < 0.05) with serum magnesium. The genetic
model was assumed to be additive. Genome-wide signifi-
cance was defined by a p-value <5x10−8, and suggestive
significance was defined by a p-value <10−6. For the nine
index SNPs for serum magnesium previously identified in
EA populations, the significance threshold was set at 0.05
divided by the number of SNPs (=0.006). Since allelic het-
erogeneity and differences in linkage disequilibrium pat-
tern between EA and AA populations may give rise to
different tag SNPs in an associated region, we evaluated
the association of each locus previously identified in EA
populations [6] in the GWAS results of ARIC AA partici-
pants based on a set of criteria similar to those developed
in Liu et al. [24]. The region-specific significant threshold
was defined as p-value <0.05 divided by the number of in-
dependent SNPs in the region of the locus. The span of
the region was defined as between the two closest recom-
bination hot spots on both sides of the published index
SNP, or the length of gene containing the index SNP,
whichever was larger. The number of independent SNPs
at each locus was determined using PLINK [25] by prun-
ing SNPs with variance inflation factor > 2 using a 50-SNP
sliding window with a shift of 5 SNPs.
Replication
The index SNPs with suggestive significance in the GWAS
of ARIC AA participants and the ARIC AA-specific index
SNPs in known EA loci were sent forth for replication in
the HANDLS study using the same regression model. The
significant criteria for replication were set as p-value < 0.05
with consistent direction of association. We performed
fixed effect meta-analysis [26] combining the results fromAA participants of the ARIC and HANDLS studies. A
known EA locus was considered to be associated in AA
populations if the AA-specific index SNP from the ARIC
study met the replication criteria and the region-specific
significance threshold.
Enhancer enrichment test
Since loci associated with complex traits identified in
GWAS tend to reside in regulatory regions [27], for the
three AA-associated loci (MUC1, SHROOM3, and
TRPM6) that were replicated in the HANDLS study, we
conducted enhancer enrichment test using HaploReg ver-
sion 2 [28]. At each locus, the SNPs used in the tests were
those with D’ > 0.9 and r2 > 0.2 with the AA-specific index
SNP based on 1000 Genomes Phase 1 AFR data and re-
trieved from HaploReg. The numbers of SNPs used were
58 atMUC1, 11 at SHROOM3, and 27 at TRPM6.
Gene-environment interaction analyses for MUC1 and
TRPM6
To investigate gene-environment interaction, we focused
on MUC1 and TRPM6. In addition to being the loci that
had the largest effect estimates in EA participants, both
loci are known to be involved in nutrient transport [10]
with TRPM6 being a magnesium transporter [16]. Their
gene functions support them as the causal genes in the
GWAS-identified loci. The index SNP at MUC1 in EA
populations, rs4072037, seems to be located in a regula-
tory region based on data from RegulomeDB [14] and in
moderate linkage disequilibrium with an expression tag
SNP of MUC1 (rs4971093 at 155,144,300 bp) based on
data from the Genotype-Tissue Expression (GTEx) pro-
ject [15]. We searched the literature for factors that in-
fluence the expression levels of MUC1 and TRPM6 and
found that progesterone regulates MUC1 [12], and insu-
lin regulates TRPM6 [9]. Hence we tested for the effect
modification between progestin use and MUC1 and be-
tween fasting insulin levels and TRPM6 in relation to
serum magnesium levels.
The analyses for gene-environment interaction were
conducted within each self-reported race group in the fol-
lowing steps. First, the potential effect modifier was coded
as a categorical variable. For progestin use, gender, post-
menopausal status, and hormone use were combined into
a categorical variable with 5 categories: males, premeno-
pausal females, postmenopausal females with hormone
therapy, postmenopausal females with non-progestin hor-
mone therapy, and postmenopausal females with progestin
use. Fasting insulin levels were categorized into two levels
at 80 mmol/L, which is considered as a threshold indicat-
ing insulin resistance [29, 30]. Second, we tested for the
independence between the most likely genotype of the
index SNP and the potential effect modifier using Chi-
square tests. Third, we performed linear regression using
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same covariates used in the GWAS of ARIC AA partici-
pants and tested for statistical interaction between the po-
tential effect modifier and the index SNPs at the locus.
Fourth, we evaluated the association between the index
SNP and serum magnesium within each category of the
effect modifier. For the evaluation of effect modification
between insulin and the TRPM6 index SNP, participants
who did not fast for 8 hours before blood drawn (182 in
EA and 187 in AA) or were taking insulin (55 in EA and
61 in AA) were excluded, resulting in a sample size of
8689 in EA participants and 2488 in AA participants.
In addition, two nonsynonymous SNPs (nsSNPs) at
TRPM6 were reported to inhibit the expression of TRPM6
in response to higher insulin levels (rs2274924 [K1584E]
and rs3750425 [V1393I]) [9]. To determine whether the
association between the GWAS index SNPs and serum
magnesium were independent of these two nsSNPs, we
estimated the linkage disequilibrium as measured by D’
between the GWAS index SNPs and these two nsSNPs at
TRPM6. D’ was used as the measure of linkage disequilib-
rium here because it estimates whether two variants are
on the same haplotype across allele frequencies. Next, we
evaluated the association between these two nsSNPs and
serum magnesium by fasting insulin levels with and with-
out controlling for the GWAS index SNP at TRPM6.
To assess the required sample size for replicating the
gene-environment interaction in other cohorts, we con-
ducted a post-hoc power analysis by simulating the distri-
butions of genotypes and effect sizes found in ARIC EA
participants. Using an alpha of 0.05, the power for detect-
ing an interaction between the index SNP at MUC1 and
postmenopausal females with progestin use versus male
was 27 % for a sample size of 3000, and 68 % for a sample
size of 9000. For the interaction between the index SNP at
TRPM6 and insulin levels, the power was 34 % for a sam-
ple size of 3000, and 75 % for a sample size of 9000.
Software
Linkage disequilibrium in ARIC study as measured by r2
and D’ was estimated using PLINK 1.07 [25] based on
most likely genotypes derived from imputed dosage. The
percentage of phenotypic variance explained by a SNP was
estimated by calculating the effect size of the SNP
(2β2xMAFx[1-MAF]) [31] divided by the phenotypic vari-
ance. Regression analyses were performed using the im-
puted dosage of the genotype. GWAS was conducted
using SNPTEST 2.4.1 [32]. Fixed effect meta-analyses
were conducted using metal [26]. Other analyses were per-
formed using R. The present study has been approved by
the respective Institutional Review Boards of the ARIC
study and the HANDLS study and was performed in ac-
cordance with the Declaration of Helsinki. All participants
provided informed consent.Availability of supporting data
The data set supporting the results of this article is available




Additional file 1: Figure S1. Quantile-quantile plot of the P-values of the
GWAS of serum magnesium in African-American participants in the ARIC
study. Genomic control factor: 1.008. Figure S2a and b. Regional association
plot of the MUC1 locus from the GWAS in ARIC African Americans. 2A shows
the closest recombination hot spots on both sides of the index SNP, and 2B
provides a close-up view of the region. Figure S3 Regional association
plot of the SHROOM3 locus in ARIC African Americans. Figure S4 Regional
association plot of the TRPM6 locus in ARIC African Americans. Table S1
Association of Index SNPs in published Loci of Serum Magnesium Identified
in Populations of European Ancestry1 in African Americans in the ARIC and
HANDLS Studies. Table S2 Linkage Disequilibrium between the Index
SNPs in Populations of European and African Ancestries at the MUC1
Locus (rs4072037 and rs2974937). Table S3 Novel Loci with Suggestive
Significance (P-Value < 1e-7) in the GWAS of Serum Magnesium in ARIC
African Americans with Replication Results from the HANDLS Study.
Table S4 Association between Genotyped SNPs in the MUC1 and
TRPM6 Region with Serum Magnesium in ARIC African-Americans.
Table S5 Results of Enhancer Enrichment Tests at Three Replicated
Serum Magnesium Loci (MUC1, SHROOM3, and TRPM6) of African Americans
using HaploReg. Table S6 Linkage Disequilibrium (D’) of GWAS Index SNPs
and Two Nonsynonymous SNPs (rs2274924 and rs3750425) Reported to
Influence TRPM6 Expression1 at the TRPM6 Locus in ARIC European- and
African-Americans. Table S7 Association between Two Nonsynonymous
SNPs (rs2274924 and rs3750425) Reported to Influence TRPM6 Expression1
and Serum Magnesium by Fasting Insulin Strata in ARIC European- and
African-Americans. Supplementary Methods: Genotyping and Imputation
in the ARIC study.
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